NASDAQ : LEXX

Lexaria Bioscience Corp. — Financial statements

Healthcare · Biotechnology · Canada

Last price 3.49 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.35M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Lexaria Bioscience Corp. (LEXX) reported revenue of 194.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year September - August; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue194.00K705.92K464.28K226.21K255.40K722.74K
Cost of Revenue2.72K4.82K31.50K71.84K175.35K
Gross Profit194.00K703.20K459.46K194.71K183.56K547.39K
Selling, General & Admin3.69M4.10M3.79M2.96M4.96M4.97M
Research & Development4.00M8.24M2.36M3.67M1.84M1.26M
Operating Expenses7.69M12.34M6.15M6.62M6.80M6.23M
Operating Income-7.49M-11.63M-5.70M-6.43M-6.62M-5.69M
Interest & Investment Income5.43K3.02K14.31K43.19K
EBT Excluding Unusual Items-7.49M-11.63M-5.68M-6.38M-6.62M-5.69M
Gain (Loss) on Sale of Investments-33.54K-33.71K-69.83K-221.69K-764.61K
Asset Writedown-213.82K-247.36K-57.84K-106.76K
Pretax Income-7.74M-11.91M-5.81M-6.71M-7.38M-5.69M
Earnings From Continuing Operations-7.74M-11.91M-5.81M-6.71M-7.38M-5.69M
Earnings From Discontinued Operations1.50M
Net Income to Company-7.74M-11.91M-5.81M-6.71M-7.38M-4.19M
Minority Interest in Earnings8.42K9.59K13.31K47.63K114.33K159.14K
Net Income-7.73M-11.90M-5.80M-6.66M-7.27M-4.03M
Net Income to Common-7.73M-11.90M-5.80M-6.66M-7.27M-4.03M
Shares Outstanding (Basic)1.50M1.20M825.60K440.94K392.35K292.76K
Shares Outstanding (Diluted)1.50M1.20M825.60K440.94K392.35K292.76K
EPS (Basic)-5.14-9.92-7.02-15.12-18.53-13.76
EPS (Diluted)-5.14-9.92-7.02-15.12-18.53-13.76
Free Cash Flow-7.47M-10.48M-5.00M-5.91M-4.93M-3.99M
Free Cash Flow Per Share-4.97-8.73-6.06-13.41-12.56-13.63
Gross Margin100.00%99.61%98.96%86.08%71.87%75.74%
Operating Margin-3,862.94%-1,647.97%-1,226.70%-2,841.31%-2,591.67%-786.85%
Profit Margin-3,985.58%-1,686.00%-1,248.25%-2,946.36%-2,846.28%-557.19%
Free Cash Flow Margin-3,848.61%-1,483.88%-1,077.38%-2,614.84%-1,929.75%-552.02%
EBITDA-7.42M-11.55M-5.62M-6.28M-6.52M-5.58M
D&A For EBITDA76.57K87.83K76.15K145.40K102.72K111.72K
EBIT-7.49M-11.63M-5.70M-6.43M-6.62M-5.69M

Balance sheet

Fiscal year September - August; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents3.48M1.80M6.50M1.35M5.81M10.92M
Short-Term Investments142.10K165.36K55.81K125.64K347.33K833.84K
Cash & Short-Term Investments3.62M1.97M6.56M1.48M6.16M11.75M
Accounts Receivable174.00K84.00K24.64K117.62K16.55K
Other Receivables49.00K194.36K70.48K102.05K84.16K325.85K
Receivables49.00K368.36K154.48K126.69K201.78K342.40K
Inventory38.42K29.65K
Prepaid Expenses398.76K1.13M1.19M546.78K576.76K319.25K
Total Current Assets4.06M3.47M7.90M2.15M6.98M12.44M
Property, Plant & Equipment313.43K334.94K389.55K421.59K367.95K459.25K
Other Intangible Assets339.02K307.82K516.68K462.62K488.46K364.62K
Other Long-Term Assets64.01K64.01K63.58K48.56K
Total Assets4.78M4.18M8.87M3.08M7.83M13.27M
Accounts Payable104.61K569.75K379.88K225.04K120.15K59.89K
Accrued Expenses245.76K893.29K686.53K14.90K31.30K45.00K
Short-Term Debt7.93K
Current Portion of Leases33.03K30.42K28.05K27.79K42.59K39.40K
Current Income Taxes Payable1.05K
Current Unearned Revenue4.96K
Total Current Liabilities383.41K1.49M1.10M267.74K194.04K153.28K
Long-Term Leases53.68K78.90K109.32K136.17K7.40K49.99K
Total Liabilities437.09K1.57M1.21M403.91K201.44K203.26K
Common Stock24.79K19.56K15.81K8.09K5.95K5.73K
Additional Paid-In Capital73.26M66.50M59.60M48.80M47.04M45.09M
Retained Earnings-68.50M-63.46M-51.56M-45.76M-39.10M-31.83M
Comprehensive Income & Other-46.47K-70.33K-19.82K
Total Common Equity4.74M2.99M8.04M3.04M7.95M13.27M
Minority Interest-393.97K-386.94K-377.35K-364.04K-316.41K-202.09K
Shareholders' Equity4.34M2.60M7.66M2.68M7.63M13.06M
Total Liabilities & Equity4.78M4.18M8.87M3.08M7.83M13.27M
Total Debt86.71K109.32K137.37K163.97K49.99K97.32K
Net Cash (Debt)3.53M1.86M6.42M1.31M6.11M11.65M
Net Cash Per Share2.351.557.772.9815.5739.81
Filing Date Shares Outstanding1.65M1.48M1.16M685.11K396.73K381.78K
Total Common Shares Outstanding1.65M1.30M1.05M539.44K396.73K381.78K
Working Capital3.68M1.97M6.80M1.88M6.78M12.29M
Book Value Per Share2.872.297.625.6420.0434.75
Tangible Book Value4.40M2.68M7.52M2.58M7.46M12.90M
Tangible Book Value Per Share2.662.067.134.7918.8033.79
Machinery577.81K536.99K512.34K469.33K435.52K386.32K
Leasehold Improvements259.98K259.98K259.98K259.98K259.98K259.98K

Cash flow statement

Fiscal year September - August; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-7.73M-11.90M-5.80M-6.66M-7.27M-4.03M
Depreciation & Amortization106.17K115.85K108.76K186.96K141.31K147.60K
Asset Writedown & Restructuring Costs213.82K247.36K57.84K106.76K
Loss (Gain) From Sale of Investments33.54K33.71K69.83K221.69K764.61K166.25K
Stock-Based Compensation365.46K859.49K492.24K170.38K1.95M1.28M
Provision & Write-off of Bad Debts7.76K50.50K
Other Operating Activities-945.00-546.00-6.64K-45.40K-117.06K-148.75K
Change in Accounts Receivable309.13K-213.88K-35.55K26.54K-137.49K189.58K
Change in Inventory43.07K-1.98K95.04K
Change in Accounts Payable-1.11M396.64K826.47K88.49K50.73K13.80K
Change in Unearned Revenue1.00-4.96K4.96K-44.26K
Change in Other Net Operating Assets387.24K17.78K-689.32K-14.84K-262.73K-190.64K
Operating Cash Flow-7.43M-10.45M-4.96M-5.88M-4.88M-3.99M
Capital Expenditures-40.82K-24.65K-43.01K-33.75K-49.19K
Sale of Property, Plant & Equipment273.37K
Sale (Purchase) of Intangibles-61.05K-75.11K-145.59K-135.86K-131.45K-79.49K
Investment in Securities-142.10K-143.27K
Investing Cash Flow-243.97K-243.02K-188.60K-169.61K-180.64K193.88K
Long-Term Debt Repaid-44.60K-66.69K
Lease Payments-44.60K-43.95K
Net Debt Issued (Repaid)-44.60K-66.69K
Issuance of Common Stock6.52M6.05M10.32M1.59M13.49M
Financing Cash Flow6.52M6.05M10.32M1.59M-44.60K13.42M
Foreign Exchange Rate Adjustments34.60K-50.52K-19.82K
Net Cash Flow-1.12M-4.70M5.15M-4.46M-5.10M9.62M
Free Cash Flow-7.47M-10.48M-5.00M-5.91M-4.93M-3.99M
Free Cash Flow Margin-3,848.61%-1,483.88%-1,077.38%-2,614.84%-1,929.75%-552.02%
Free Cash Flow Per Share-4.97-8.73-6.06-13.41-12.56-13.63
Levered Free Cash Flow-4.69M-6.16M-2.98M-3.60M-2.30M-2.37M
Unlevered Free Cash Flow-4.69M-6.16M-2.98M-3.60M-2.30M-2.37M
Free Cash Flow After Leases-7.47M-10.48M-5.00M-5.91M-4.97M-4.03M
Cash Income Tax Paid4.40K8.21K-4.78K-16.30K
Change in Working Capital-411.51K195.58K106.56K143.26K-351.48K63.53K

Ratios

Fiscal year September - August; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization7.35M17.22M61.82M8.50M17.61M35.36M
Enterprise Value3.82M12.32M53.08M4.88M10.07M26.88M
Last Close Price3.4913.2058.6515.7544.4093.30
PS Ratio37.9024.39133.1537.5668.9748.92
PB Ratio1.226.628.073.172.312.71
P/TBV Ratio1.676.428.223.292.362.74
EV/Sales Ratio19.7017.46114.3321.5839.4437.19
Debt / Equity Ratio0.020.040.020.060.010.01
Net Debt / Equity Ratio-0.81-0.71-0.84-0.49-0.80-0.89
Net Debt / EBITDA Ratio0.480.161.140.210.942.09
Net Debt / FCF Ratio0.470.181.280.221.242.92
Asset Turnover0.030.110.080.040.020.09
Inventory Turnover2.112.39
Quick Ratio9.561.566.105.9932.7978.90
Current Ratio10.602.327.188.0435.9681.18
Return on Equity (ROE)-162.77%-232.15%-112.36%-130.18%-71.35%-73.16%
Return on Assets (ROA)-81.30%-111.49%-59.56%-73.59%-39.21%-44.17%
Return on Capital Employed (ROCE)-170.40%-433.80%-73.30%-228.20%-86.60%-43.40%
Earnings Yield-147.36%-69.12%-9.38%-78.45%-41.27%-11.39%
FCF Yield-101.56%-60.84%-8.09%-69.63%-27.98%-11.28%
Buyback Yield / Dilution-32.40%-45.34%-87.24%-12.38%-34.02%-58.34%